Exchange: NASDAQ·Updated 06:18 PM EDT
BMRN logo

BMRNBiomarin Pharmaceutical Inc. - Registered Shares

$59.20
$0.08
(0.14%)
Today
Closed $59.20
$0.00
(0.00%)
After Hours
EarningsAug 3
Mkt Cap$11.43B
Vol1.59M

About

BioMarin Pharmaceutical, Inc. is a global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. The company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
3,221

Frequently Asked Questions

What is Market Cap of Biomarin Pharmaceutical Inc. - Registered Shares?
What is the 52-week high for Biomarin Pharmaceutical Inc. - Registered Shares?
What is the 52-week low for Biomarin Pharmaceutical Inc. - Registered Shares?
What is Biomarin Pharmaceutical Inc. - Registered Shares stock price today?
What was Biomarin Pharmaceutical Inc. - Registered Shares stock price yesterday?
What is the PE ratio of Biomarin Pharmaceutical Inc. - Registered Shares?
What is the Price-to-Book ratio of Biomarin Pharmaceutical Inc. - Registered Shares?
What is the 50-day moving average of Biomarin Pharmaceutical Inc. - Registered Shares?
How many employees does Biomarin Pharmaceutical Inc. - Registered Shares have?

Advertisement|Remove ads.